KJIM :: Korean Journal of Internal Medicine

Effects of statin therapy on glycemic control and insulin resistance: A systematic review and meta-analysis

Laura Alvarez-Jimenez, Felix Morales-Palomo, Alfonso Moreno-Cabañas, Juan F. Ortega, Ricardo Mora-Rodríguez

European Journal of Pharmacology.2023; 947: 175672. CrossRef

The Efficacy of Atorvastatin and Rosuvastatin on the Changes of alpha and beta Apolipoproteins; A Systematic Review and Meta-Analysis

Journal of Advances in Medical and Biomedical Research.2023; 31(145): 109. CrossRef

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia

Hae Won Jung, Chang‐Yeon Kim, Seung‐Pyo Hong, Han‐Joon Bae, Ji Yong Choi, Jae Kean Ryu, Jin‐bae Lee, Kyoung‐Hoon Lee, Kyoo‐Rok Han, Dong‐Heon Yang, Chang‐Gyu Park, Gheol‐Woong Yu, Moo‐Yong Rhee, Sung‐Ji Park, Min‐Su Hyon, Joon‐Han Shin, Bum‐Kee Hong, Han‐

The Journal of Clinical Hypertension.2023; 25(9): 828. CrossRef

Ibadete Bytyçi, Peter E Penson, Dimitri P Mikhailidis, Nathan D Wong, Adrian V Hernandez, Amirhossein Sahebkar, Paul D Thompson, Mohsen Mazidi, Jacek Rysz, Daniel Pella, Željko Reiner, Peter P Toth, Maciej Banach

Rosuvastatin-Induced Dizziness and Pruritus: A Case Report and Summary of Statin-Associated Dizziness and Pruritus

Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease

Ke Li, Meng-Meng Liu, Xin Yang, Li Chen, Hui Geng, Wei Luo, Jie Ma

Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia

Jaecheol Moon, Soyeon Yoo, Gwanpyo Koh, Kyung-Wan Min, Hyun Ho Shin

Journal of Lipid and Atherosclerosis.2020; 9(1): 162. CrossRef

Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over

Arim Kwak, Jae Hyun Kim, Cheol Ung Choi, In-Wha Kim, Jung Mi Oh, Kyungim Kim

International Journal of Clinical Pharmacy.2019; 41(2): 460. CrossRef

Eun-Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Hae Jin Kim, Seonghoon Choi, Min Kyong Moon, Jin Oh Na, Kwang-Yeol Park, Mi Sun Oh, Sang Youb Han, Junghyun Noh, Kyung Hee Yi, Sang-Hak L

The Korean Journal of Internal Medicine.2019; 34(4): 723. CrossRef

2018 Guidelines for the Management of Dyslipidemia in Korea

Journal of Lipid and Atherosclerosis.2019; 8(2): 78. CrossRef

COMPARING HIGH INTENSITY WITH LOW INTENSITY STATINS IN ACHIEVING OPTIMAL LDL GOALS AMONG CORONARY ARTERY DISEASE PATIENTS IN SUBURBAN POPULATION IN SOUTH INDIA

Vinodkumar Balakrishnan, Ramesh Sankaran, Thanikachalam S, Muralidharan T. R, Nagendra Boopathy Senguttuvan, Dasarath Boppana

Journal of Evolution of Medical and Dental Sciences.2019; 8(6): 364. CrossRef

Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease

Qianqian Chen, Xingchen Shang, Meng Yuan, Lining Liang, Xia Zhong

Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis

Ziliang Ye, Haili Lu, Qiang Su, Wenqin Guo, Weiran Dai, Hongqing Li, Huafeng Yang, Lang Li, Dalin Tang

Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial

Akiko Kameda, Akinobu Nakamura, Yoshinobu Kondo, Mari Kimura, Yasuo Terauchi

Economic Evaluation of Rosuvastatin and Atorvastatin for the Treatment of Dyslipidemia from a Korean Health System Perspective

Sunghwan Suh, Chang Hee Jung, Soon-Jun Hong, Jung-Sun Kim, Byung Ju Song, Hyun Soon Sohn, Sung Hee Choi

Journal of Lipid and Atherosclerosis.2016; 5(1): 61. CrossRef

Open‐label randomized non‐inferiority trial of a fixed‐dose combination of glimepiride and atorvastatin for the treatment of people whose Type 2 diabetes is uncontrolled on metformin

P. Ambery, A. Stylianou, G. Atkinson, C. Dott, L. Baylor Curtis, N. Haque, K. LaCroix, K. W. Min

Safety of atorvastatin in Asian patients within clinical trials

Juliana C. N. Chan, Alice P. S. Kong, Weihang Bao, Rana Fayyad, Rachel Laskey

COMPARISON OF SAFETY AND EFFICACY OF ROSUVASTATIN (10 MG) AND ATORVASTATIN (20 MG) IN CASES OF DYSLIPIDAEMIA OVER SIX WEEKS OF TREATMENT

Anubhav Gupta, Sanjeet Kumar Pandit, Anand Dev, Kumar B, Vishva Nayak

Journal of Evidence Based Medicine and Healthcare.2016; 3(43): 2142. CrossRef

Cochrane Database of Systematic Reviews.2015;[Epub] CrossRef

Cholesterol Lowering Effects of Low-dose Statins in Korean Patients

Jee Eun Kwon, Young Kim, Seonghyup Hyun, Hoyoun Won, Seung Yong Shin, Kwang Je Lee, Sang-Wook Kim, Tae Ho Kim, Chee Jeong Kim

Journal of Lipid and Atherosclerosis.2014; 3(1): 21. CrossRef

Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases

Michael S. Kostapanos, Christos V. Rizos, Moses S. Elisaf

Statin-Associated Incident Diabetes: A Literature Review

Zoon H. Park, Alicia Juska, Detelin Dyakov, Ramesh V. Patel

Cochrane Database of Systematic Reviews.2014;[Epub] CrossRef

Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase

International Journal of Impotence Research.2013; 25(4): 143. CrossRef

Rosuvastatin Does Not Affect Fasting Glucose, Insulin Resistance, or Adiponectin in Patients with Mild to Moderate Hypertension

Weon Kim, Myong Joo Hong, Jong Shin Woo, Won Yu Kang, Sun Ho Hwang, Wan Kim

A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein

International Journal of Cardiology.2012; 154(1): 78. CrossRef

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

P. Anagnostis, D. Selalmatzidou, S. A. Polyzos, A. Panagiotou, A. Slavakis, A. Panagiotidou, V. G. Athyros, A. Karagiannis, D. P. Mikhailidis, M. Kita

International Journal of Clinical Practice.2011; 65(6): 679. CrossRef

Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction

Min Chul Kim, Youngkeun Ahn, Su Young Jang, Kyung Hoon Cho, Seung Hwan Hwang, Min Goo Lee, Jum Suk Ko, Keun Ho Park, Doo Sun Sim, Nam Sik Yoon, Hyun Ju Yoon, Kye Hun Kim, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Myung Ho Jeong, Jeong Gwan Cho, Jong C

The Korean Journal of Internal Medicine.2011; 26(3): 294. CrossRef